Janus Henderson Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$121M Buy
1,060,734
+33,185
+3% +$3.77M 0.06% 241
2025
Q1
$111M Buy
1,027,549
+12,526
+1% +$1.35M 0.06% 252
2024
Q4
$109M Buy
1,015,023
+5,929
+0.6% +$635K 0.06% 266
2024
Q3
$101M Buy
1,009,094
+361
+0% +$36.1K 0.05% 278
2024
Q2
$85M Buy
1,008,733
+256
+0% +$21.6K 0.05% 284
2024
Q1
$73.7M Sell
1,008,477
-334,677
-25% -$24.5M 0.04% 315
2023
Q4
$95.9M Buy
1,343,154
+1,281
+0.1% +$91.5K 0.06% 258
2023
Q3
$80.4M Sell
1,341,873
-2,682
-0.2% -$161K 0.05% 269
2023
Q2
$96.9M Buy
1,344,555
+84,670
+7% +$6.1M 0.06% 259
2023
Q1
$92.7M Buy
1,259,885
+4,612
+0.4% +$339K 0.06% 263
2022
Q4
$83.9M Sell
1,255,273
-2,791,767
-69% -$186M 0.06% 269
2022
Q3
$217M Buy
4,047,040
+1,819,691
+82% +$97.8M 0.08% 225
2022
Q2
$124M Buy
2,227,349
+675
+0% +$37.6K 0.09% 225
2022
Q1
$156M Sell
2,226,674
-83,385
-4% -$5.85M 0.08% 241
2021
Q4
$223M Sell
2,310,059
-34,970
-1% -$3.37M 0.09% 217
2021
Q3
$204M Buy
2,345,029
+29,943
+1% +$2.6M 0.09% 232
2021
Q2
$189M Buy
2,315,086
+298,837
+15% +$24.5M 0.08% 246
2021
Q1
$192M Sell
2,016,249
-568,379
-22% -$54.1M 0.09% 228
2020
Q4
$160M Buy
2,584,628
+10,144
+0.4% +$629K 0.07% 268
2020
Q3
$153M Buy
2,574,484
+1,711
+0.1% +$102K 0.08% 245
2020
Q2
$180M Buy
2,572,773
+21,467
+0.8% +$1.5M 0.1% 213
2020
Q1
$116M Sell
2,551,306
-362,105
-12% -$16.4M 0.08% 252
2019
Q4
$190M Buy
2,913,411
+403,078
+16% +$26.2M 0.1% 225
2019
Q3
$156M Buy
2,510,333
+37,433
+2% +$2.32M 0.08% 261
2019
Q2
$176M Buy
2,472,900
+252,639
+11% +$18M 0.1% 243
2019
Q1
$174M Buy
2,220,261
+635,054
+40% +$49.8M 0.1% 244
2018
Q4
$134M Buy
1,585,207
+142,368
+10% +$12.1M 0.09% 278
2018
Q3
$247M Sell
1,442,839
-43,304
-3% -$7.42M 0.13% 195
2018
Q2
$192M Buy
1,486,143
+88,149
+6% +$11.4M 0.11% 237
2018
Q1
$144M Sell
1,397,994
-67,765
-5% -$6.98M 0.08% 277
2017
Q4
$125M Buy
1,465,759
+255,988
+21% +$21.9M 0.08% 314
2017
Q3
$103M Buy
1,209,771
+255,199
+27% +$21.7M 0.07% 354
2017
Q2
$72.3M Buy
+954,572
New +$72.3M 0.05% 427